Tavintharan S - Search Results

1

Circulating microRNAs as biomarkers of acute stroke.

Sepramaniam S, Tan JR, Tan KS, DeSilva DA, Tavintharan S, Woon FP, Wang CW, Yong FL, Karolina DS, Kaur P, Liu FJ, Lim KY, Armugam A, Jeyaseelan K. Sepramaniam S, et al. Among authors: tavintharan s. Int J Mol Sci. 2014 Jan 20;15(1):1418-32. doi: 10.3390/ijms15011418. Int J Mol Sci. 2014. PMID: 24447930 Free PMC article.

2

Circulating miRNA profiles in patients with metabolic syndrome.

Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, Wong MT, Lim SC, Sum CF, Jeyaseelan K. Karolina DS, et al. Among authors: tavintharan s. J Clin Endocrinol Metab. 2012 Dec;97(12):E2271-6. doi: 10.1210/jc.2012-1996. Epub 2012 Oct 2. J Clin Endocrinol Metab. 2012. PMID: 23032062

3

MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, Sum CF, Jeyaseelan K. Karolina DS, et al. Among authors: tavintharan s. PLoS One. 2011;6(8):e22839. doi: 10.1371/journal.pone.0022839. Epub 2011 Aug 1. PLoS One. 2011. PMID: 21829658 Free PMC article.

4

Riboregulators and metabolic disorders: getting closer towards understanding the pathogenesis of diabetes mellitus?

Tavintharan S, Chi LS, Fang SC, Arunmozhiarasi A, Jeyaseelan K. Tavintharan S, et al. Curr Mol Med. 2009 Apr;9(3):281-6. doi: 10.2174/156652409787847245. Curr Mol Med. 2009. PMID: 19355910 Review.

5

Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and Type 2 diabetes.

Pek SL, Sum CF, Lin MX, Cheng AK, Wong MT, Lim SC, Tavintharan S. Pek SL, et al. Among authors: tavintharan s. Mol Cell Endocrinol. 2016 May 15;427:112-23. doi: 10.1016/j.mce.2016.03.010. Epub 2016 Mar 10. Mol Cell Endocrinol. 2016. PMID: 26973292

6

MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation.

Pek SL, Tavintharan S, Woon K, Lin L, Ong CN, Lim SC, Sum CF. Pek SL, et al. Among authors: tavintharan s. Exp Biol Med (Maywood). 2016 Feb;241(3):317-30. doi: 10.1177/1535370215605588. Epub 2015 Sep 30. Exp Biol Med (Maywood). 2016. PMID: 26429200 Free PMC article. Clinical Trial.

7

Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program.

Nang EE, Khoo CM, Tai ES, Lim SC, Tavintharan S, Wong TY, Heng D, Lee J. Nang EE, et al. Among authors: tavintharan s. Am J Epidemiol. 2009 Jun 15;169(12):1454-62. doi: 10.1093/aje/kwp076. Epub 2009 Apr 30. Am J Epidemiol. 2009. PMID: 19406920

8

Relationship between circulating irisin, renal function and body composition in type 2 diabetes.

Liu JJ, Liu S, Wong MD, Tan CS, Tavintharan S, Sum CF, Lim SC. Liu JJ, et al. Among authors: tavintharan s. J Diabetes Complications. 2014 Mar-Apr;28(2):208-13. doi: 10.1016/j.jdiacomp.2013.09.011. Epub 2013 Oct 4. J Diabetes Complications. 2014. PMID: 24332937

9

Lower circulating irisin is associated with type 2 diabetes mellitus.

Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC. Liu JJ, et al. Among authors: tavintharan s. J Diabetes Complications. 2013 Jul-Aug;27(4):365-9. doi: 10.1016/j.jdiacomp.2013.03.002. Epub 2013 Apr 22. J Diabetes Complications. 2013. PMID: 23619195

10

Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.

Xu F, Tavintharan S, Sum CF, Woon K, Lim SC, Ong CN. Xu F, et al. Among authors: tavintharan s. J Clin Endocrinol Metab. 2013 Jun;98(6):E1060-5. doi: 10.1210/jc.2012-4132. Epub 2013 Apr 30. J Clin Endocrinol Metab. 2013. PMID: 23633210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page